Literature DB >> 10687744

Apolipoprotein E phenotypes in healthy normal controls and demented subjects with Alzheimer's disease and vascular dementia in Mie Prefecture of Japan.

S Nakayama1, S Kuzuhara.   

Abstract

In order to clarify the association between apolipoprotein E4 (ApoE4) and the pathogenesis of Alzheimer's disease (AD), we analyzed the distribution of the apolipoprotein E (ApoE) phenotypes and the frequency of the apo E alleles epsilon2, epsilon3, and epsilon4 in Japanese healthy controls (n = 1090, an average age of 51.2+/-12.6 years) and demented patients (n=103, mean age of 73.6+/-9.2 years). Demented subjects were divided into three subgroups: early-onset AD group (EOAD; n=25, mean age 63.0+/-6.2 years), late-onset AD group (LOAD; n=33, mean age 79.3+/-5.1 years), and vascular dementia group (VD; n=45, mean age 75.3+/-8.0 years). The apolipoprotein E phenotype was determined by isoelectric focusing and immunoblotting. There were no significant differences in the distribution of the apo E phenotypes by gender or age, and the estimated frequencies of epsilon2, epsilon3 and epsilon4 were 0.05, 0.86 and 0.09, respectively, in the normal controls. There was a significant difference in the distribution of the apo E phenotypes between LOAD and elderly controls aged more than 65 years (P<0.0001). The distribution of the apo E phenotypes in EOAD was the same as that in LOAD. The frequency of the epsilon4 allele was significantly higher in LOAD (0.35, P<0.0001) and EOAD (0.28, P<0.0001) than that in the control subjects (0.07), but not in VD (0.12, P=0.1630). The present findings suggest that ApoE4 is related with both EOAD and LOAD, but not with VD, and support the hypothesis that it is a genetic risk factor of AD.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10687744     DOI: 10.1046/j.1440-1819.1999.00619.x

Source DB:  PubMed          Journal:  Psychiatry Clin Neurosci        ISSN: 1323-1316            Impact factor:   5.188


  7 in total

1.  ApoE gene polymorphism and vascular dementia in Chinese population: a meta-analysis.

Authors:  Xu Liu; Lei Li; Fang Liu; Shuming Deng; Ruixia Zhu; Qu Li; Zhiyi He
Journal:  J Neural Transm (Vienna)       Date:  2011-10-09       Impact factor: 3.575

Review 2.  Is apolipoprotein E4 an important risk factor for vascular dementia?

Authors:  Troy T Rohn
Journal:  Int J Clin Exp Pathol       Date:  2014-06-15

3.  Association between APOE epsilon4 allele and vascular dementia: The Cache County study.

Authors:  Yi-Fang Chuang; Kathleen M Hayden; Maria C Norton; Joann Tschanz; John C S Breitner; Kathleen A Welsh-Bohmer; Peter P Zandi
Journal:  Dement Geriatr Cogn Disord       Date:  2010-04-06       Impact factor: 2.959

4.  APOE, MTHFR, LDLR and ACE polymorphisms among Angami and Lotha Naga populations of Nagaland, India.

Authors:  Benrithung Murry; Neikethono Vakha; Nongthombam Achoubi; M P Sachdeva; K N Saraswathy
Journal:  J Community Health       Date:  2011-12

5.  Lack of Association between Apolipoprotein E Polymorphism with Age at Onset of Subcortical Vascular Dementia.

Authors:  Hye Guk Ryu; Sung-Won Youn; Oh Dae Kwon
Journal:  Dement Geriatr Cogn Dis Extra       Date:  2012-01-19

6.  Dementia risk by combinations of metabolic diseases and body mass index: Japan Gerontological Evaluation Study Cohort Study.

Authors:  Hiroshi Yokomichi; Katsunori Kondo; Yuiko Nagamine; Zentaro Yamagata; Naoki Kondo
Journal:  J Diabetes Investig       Date:  2019-07-02       Impact factor: 4.232

7.  APOE ε4 Allele Distribution and Association With Scores of Subjective Cognitive Decline Questionnaire 9 in a Large Chinese Memory Clinic Cohort.

Authors:  Lixiao Hao; Jianguo Jia; Yue Xing; Ying Han
Journal:  Front Neurosci       Date:  2022-06-03       Impact factor: 5.152

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.